Racial and ethnic composition as a correlate of medication availability within addiction treatment organizations

Sociological Focus

Volumn 42, Issue 2, 2009, Pages 133-151

  Knudsen, Hannah K ^a   Roman, Paul M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950735789     PISSN: 00380237     EISSN: 21621128     Source Type: Journal    
DOI: 10.1080/00380237.2009.10571347     Document Type: Article

References (84)

1. Alegria, Margarita, Glorisa Canino, Ruth Rios, Mildred Vera, José Calderon, Dana Rusch, and Alexander N. Ortega. 2002. “Inequalities in Use of Specialty Mental Health Services among Latinos, African Americans, and Non-Latino Whites.” Psychiatric Services 53:1547-1555.
2. Allison, Paul D. 1999. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Publishing.
3. Barnato, Amber E., F. Lee Lucas, Douglas Staiger, David E. Wennberg, and Amitabh Chandra. 2005. “Hospital-Level Racial Disparities in Acute Myocardial Infarction Treatment and Outcomes.” Medical Care 43:308-319.
4. Barnato, Amber E., Zekarias Berhane, Lisa A. Weissfield, Chung-Chou H. Chang, Walter T. Linde-Zwirble, and Derek C. Angus. 2006. “Racial Variation in End-of-Life Intensive Care Use: A Race or Hospital Effect?” Health Services Research 41:2219-2237.
5. Blau, Peter M. 1977. Inequality and Heterogeneity. New York: Free Press.
6. Bluthenthal, Ricky N., Jerry O. Jacobson, and Paul L. Robinson. 2007. “Are Racial Disparities in Alcohol Treatment Completion Associated with Racial Differences in Treatment Modality Entry? Comparison of Outpatient Treatment and Residential Treatment in Los Angeles County, 1998 to 2000.” Alcoholism: Clinical and Experimental Research 31:1920-1926.
7. Bogart, Laura M., Sheryl L. Catz, Jeffrey A. Kelly, and Eric G. Benotsch. 2001. “Factors Influencing Physicians’ Judgments of Adherence and Treatment Decisions for Patients with HIV Disease.” Medical Decision Making 21:28-36.
8. Brower, Kirk J. and Theadia L. Carey. 2003. “Racially Related Health Disparities and Alcoholism Treatment Outcomes.” Alcoholism: Clinical and Experimental Research 27:1365-1367.
9. Burgess, Diana J., Michelle van Ryn, Megan Crowley-Matoka, and Jennifer Malat. 2006. “Understanding the Provider Contribution to Race/Ethnicity Disparities in Pain Treatment: Insights from Dual Process Models of Stereotyping.” Pain Medicine 7:119-134.
10. Caetano, Raul. 1989. “Concepts of Alcoholism among Whites, Blacks and Hispanics in the United States.” Journal of Studies on Alcohol 50:580-582.
11. Caetano, Raul. 2003. “Alcohol-Related Health Disparities and Treatment-Related Epidemiological Findings among Whites, Blacks, and Hispanics in the United States.” Alcoholism: Clinical and Experimental Research 27:1337-1339.
12. Campbell, Cynthia I., Constance Weisner, and Stacy Sterling. 2006. “Adolescents Entering Chemical Dependency Treatment in Private Managed Care: Ethnic Differences in Treatment Initiation and Retention.” Journal of Adolescent Health 38:343-350.
13. Cartwright, William S. and Paul L. Solano. 2003. “The Economics of Public Health: Financing Drug Abuse Treatment Services.” Health Policy 66:247-260.
14. Chow, Julian Chun-Chung, Kim Jaffee, and Lonnie Snowden. 2003. “Racial/Ethnic Disparities in the Use of Mental Health Services in Poverty Areas.” American Journal of Public Health 93:792-797.
15. Clarke, Sean P., Bertha L. Davis, and Regina E. Nailon. 2007. “Racial Segregation and Differential Outcomes in Hospital Care.” Western Journal of Nursing Research 29:739-757.
16. Daley, Marilyn. 2005. “Race, Managed Care, and the Quality of Substance Abuse Treatment.” Administration and Policy in Mental Health 32:457-476.
17. Doescher, Mark P., Barry G. Saver, Peter Franks, and Kevin Fiscella. 2000. “Racial and Ethnic Disparities in Perceptions of Physician Style and Trust.” Archives of Family Medicine 9:1156-1163.
18. Ducharme, Lori J., Hannah K. Knudsen, and Paul M. Roman. 2006. “Trends in the Adoption of Medications for Alcohol Dependence.” Journal of Clinical Psychopharmacology 26: S13- 19.
19. Fiscella, Kevin, Peter Franks, Marthe R. Gold, and Carolyn M. Clancy. 2000. “Inequality in Quality: Addressing Socioeconomic, Racial, and Ethnic Disparities in Health Care.” JAMA 283:2579-2584.
20. Ford, Marvella E. and P. Adam Kelly. 2005. “Conceptualizing and Categorizing Race and Ethnicity in Health Services Research.” Health Services Research 40:1658-1675.
21. Fuller, Bret E., Traci Rieckmann, Dennis McCarty, Kevin W. Smith, and Helen Levine. 2005. “Adoption of Naltrexone to Treat Alcohol Dependence.” Journal of Substance Abuse Treatment 28:273-280.
22. Gilbert, Gregg H., Mark S. Litaker, and Sonia K. Makhija. 2007. “Differences in Quality between Dental Practices Associated with Race and Income Mix of Patients.” Journal of Health Care for the Poor and Underserved 18:847-867.
23. Groeneveld, Peter, Sara B. Laufer, and Alan M. Garber. 2005. “Technology Diffusion, Hospital Variation, and Racial Disparities among Elderly Medicare Beneficiaries: 1989-2000.” Medical Care 43:320-329.
24. Harman, Jeffrey S., Mark J. Edlund, and John C. Fortney. 2004. “Disparities in the Adequacy of Depression Treatment in the United States.” Psychiatric Services 55:1379-1385.
25. Hasnain-Wynia, Romana, David W. Baker, David Nerenz, Joe Feinglass, Anne C. Beal, Mary Beth Landrum, Raj Behai, and Joel S. Weissman. 2007. “Disparities in Health Care Are Driven by Where Minority Patients Seek Care.” Archives of Internal Medicine 167:1233-1239.
26. Institute of Medicine (IOM). 1998. Bridging the Gap between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press.
27. Institute of Medicine (IOM). 2003. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, DC: National Academy Press.
28. Institute of Medicine (IOM). 2006. Improving the Quality of Health Care for Mental and Substance-Use Disorders: Quality Chasm Series. Washington, DC: National Academy Press.
29. Jacobson, Jerry O. 2004. “Place and Attrition from Substance Abuse Treatment.” Journal of Drug Issues 34:23-50.
30. Jacobson, Jerry O., Paul L. Robinson, and Ricky N. Bluthenthal. 2007a. “Racial Disparities in Completion Rates from Publicly Funded Alcohol Treatment: Economic Resources Explain More Than Demographics and Addiction Severity.” Health Services Research 42:773-794.
31. Jacobson, Jerry O., Paul L. Robinson, and Ricky N. Bluthenthal. 2007b. “A Multilevel Decomposition Approach to Estimate the Role of Program Location and Neighborhood Disadvantage in Racial Disparities in Alcohol Treatment Completion.” Social Science and Medicine 64:462-476.
32. Johnson, Rachel L., Debra Roter, Neil R. Powe, and Lisa A. Cooper. 2004. “Patient Race/Ethnicity and Quality of Patient-Physician Communication During Medical Visits.” American Journal of Public Health 94:2084-2090.
33. Kelley, Ed, Ernest Moy, Daniel Stryer, Helen Burstin, and Carolyn Clancy. 2005. “The National Healthcare Quality and Disparities Reports: An Overview.” Medical Care 43:13-18.
34. Kessler, Ronald C., Wai Tat Chiu, Olga Demler, and Ellen E. Walters. 2005. “Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Study Replication.” Archives of General Psychiatry 62:617-627.
35. Kimerling, Rachel and Nikki Baumrind. 2004. “Access to Specialty Mental Health Services among Women in California.” Psychiatric Services 56:729-734.
36. Kirby, James B. and Toshiko Kaneda. 2005. “Neighborhood Socioeconomic Disadvantage and Access to Health Care.” Journal of Health and Social Behavior 46:15-31.
37. Kirsch, Irving, Brett J. Deacon, Tania B. Huedo-Medina, Alan Scoboria, Thomas J. Moore, and Blair T. Johnson. 2008. “Initial Severity and Antidepressant Benefits: A MetaAnalysis of Data Submitted to the Food and Drug Administration.” PLoS Medicine 5:260-268.
38. Knudsen, Hannah K., Paul M. Roman, Lori J. Ducharme, and J. Aaron Johnson. 2005. “Organizational Predictors of Pharmacological Innovation Adoption: The Case of DisulHram.” Journal of Drug Issues 35:559-574.
39. Knudsen, Hannah K, Lori J. Ducharme, and Paul M. Roman. 2006. “Early Buprenorphine Adoption in Substance Abuse Treatment Centers: Data from the Private and Public Sectors.” Journal of Substance Abuse Treatment 30:363-373.
40. Knudsen, Hannah K, Lori J. Ducharme, and Paul M. Roman. 2007a. “The Adoption of Medications in Substance Abuse Treatment: Associations with Organizational Characteristics and Technology Clusters.” Drug and Alcohol Dependence 87:164-174.
41. Knudsen, Hannah K, Lori J. Ducharme, and Paul M. Roman. 2007b. “The Use of Antidepressant Medications in Substance Abuse Treatment: The Public-Private Distinction, Organizational Compatibility, and the Environment.” Journal of Health and Social Behavior 48:195-210.
42. Knudsen, Hannah K, Lori J. Ducharme, and Paul M. Roman. 2007c. “Racial and Ethnic Disparities in SSRI Availability in Substance Abuse Treatmem.” Psychiatric Services 58:55-62.
43. Koch, Alison L., Cynthia L. Arfken, and Charles R. Schuster. 2006. “Characteristics of U.S. Substance Abuse Treatment Facilities Adopting Buprenorphine in Its Initial Stage of Availability.” Drug and Alcohol Dependence 83:274-278.
44. Kuno, Eri and Aileen B. Rothbard. 2002. “Racial Disparities in Antipsychotic Prescription Patterns for Patients with Schizophrenia.” American Journal of Psychiatry 159:567-572.
45. Leslie, Laurel K., Jill Weckerly, John Landsverk, Richard L. Hough, Michael S. Hurlburt, and Patricia A. Wood. 2003. “Racial/Ethnic Differences in the Use of Psychotropic Medication in High-Risk Children and Adolescents.” Journal of the American Academy of Child and Adolescent Psychiatry 42:1433-1442.
46. Levine, Robert S., Nathaniel C. Briggs, Barbara S. Kilbourne, William D. King, Yvonne Fry- Johnson, Peter T. Baltrus, Baqar A. Husaini, and George S. Rust. 2007. “Black-White Mortality from HIV in the United States before and after Introduction of Highly Active Antiretroviral Therapy in 1996.” American Journal of Public Health 97:1884-1892.
47. Lundgren, Lena M., Maryann Amodeo, Faith Ferguson, and Karen Davis. 2001. “Racial and Ethnic Differences in Drug Treatment Entry of Injection Drug Users in Massachusetts.” Journal of Substance Abuse Treatment 21:145-153.
48. Malat, Jennifer and Mary Ann Hamilton. 2006. “Preference for Same-Race Health Care Providers and Perceptions of Interpersonal Discrimination in Health Care.” Journal of Health and Social Behavior 47:173-187.
49. Mark Tami L., Henry R. Kranzler, and Xue Song. 2003. “Understanding U.S. Addiction Physicians’ Low Rate of Naltrexone Prescription.” Drug and Alcohol Dependence 71:219-228.
50. McCarty, Dennis, Bret Fuller, Lee Ann Kaskutas, William W. Wendt, Edward V. Nunes, Michael Miller, Robert Forman, Kathryn M. Magruder, Cynthia Arfken, Marc Copersino, Anthony Floyd, Jody Sindelar, and Eldon Edmundson. 2008. “Treatment Programs in the National Drug Abuse Treatment Clinical Trials Network.” Drug and Alcohol Dependence 92:200-207.
51. McGovern, Mark P, Thomas S. Fox, Haiyi Xie, and Robert E. Drake. 2004. “A Survey of Clinical Practices and Readiness to Adopt Evidence-Based Practices: Dissemination Research in an Addiction Treatment System.” Journal of Substance Abuse Treatment 26:305-312.
52. Mee-Lee, David, Lee Gartner, Michael M. Miller, Gerald R. Shulman, and Bonnie B. Wilford. 1996. Patient Placement Criteria for the Treatment of Substance-Related Disorders. 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine (ASAM).
53. Melfi, Catherine A., Thomas W. Croghan, Mark P. Hanna, and Rebecca L. Robinson. 2000. “Racial Variation in Antidepressant Treatment in a Medicaid Population.” Journal of Clinical Psychiatry 61:16-21.
54. Miller, Susan C., George Papandonatos, Mary Fennell, and Vincent Mor. 2006. “Facility and County Effects on Racial Differences in Nursing Home Quality Indicators.” Social Science and Medicine 63:3046-3059.
55. Miller, William R., James L. Sorensen, Jeff A. Selzer, and Greg S. Brigham. 2006. “Disseminating Evidence-based Practices in Substance Abuse Treatment: A Review with Suggestions.” Journal of Substance Abuse Treatment 31:25-39.
56. Morrison, R. Sean, Sylvan Wallenstein, Dana K. Natale, Richard S. Senzel, and Lo-Li Huang. 2000. ‘“We Don’t Carry That’-Failure of Pharmacies in Predominantly Nonwhite Neighborhoods to Stock Opioid Analgesics.” New England Journal of Medicine 342:1023-1026.
57. Nunes, Edward V. and Frances R. Levin. 2004. “Treatment of Depression in Patients with Alcohol and Other Drug Dependence.” JAMA 291:1887-1896.
58. Opolka, Jayme L., Karen L. Rascati, Carolyn M. Brown, and P. J. Gibson. 2004. “Ethnicity and Prescription Patterns for Haloperidol, Risperidone, and Olanzapine.” Psychiatric Services 55:151-156.
59. Oser, Carrie B. and Paul M. Roman. 2007. “Organizational-Level Predictors of Adoption across Time: Naltrexone in Private Addiction Treatment Centers.” Journal of Studies on Alcohol and Drugs 68:852-861.
60. Rathore, Saif S. and Harlan M. Krumholz. 2004. “Differences, Disparities, and Biases: Clarifying Racial Variations in Health Care Use.” Annals of Internal Medicine 141:635-638.
61. Reskin, Barbara F., Debra B. McBrier, and Julie A. Kmec. 1999. “The Determinants and Consequences of Workplace Sex and Race Composition.” Annual Review of Sociology 25:335-361.
62. Rieckmann, Traci, Marilyn Daley, Bret E. Fuller, Cindy P. Thomas, and Dennis McCarty. 2007. “Client and Counselor Attitudes toward the Use of Medications for Treatment of Opioid Dependence.” Journal of Substance Abuse Treatment 32:207-215.
63. Rogers, Everett M. 2003. Diffusion of Innovations. 5th ed. New York: Free Press.
64. Roman, Paul M. and J. Aaron Johnson. 2002. “Adoption and Implementation of New Technologies in Substance Abuse Treatment.” Journal of Substance Abuse Treatment 22:211-218.
65. Roman, Paul M., Lori J. Ducharme, and Hannah K. Knudsen. 2006. “Patterns of Organization and Management in Private and Public Substance Abuse Treatment Programs.” Journal of Substance Abuse Treatment 31:235-243.
66. Rushton, Michael. 2008. “A Note on the Use and Misuse of the Racial Diversity Index.” Policy Studies Journal 36:445-459.
67. Saha, Somnath, Jose J. Arbelaez, and Lisa A. Cooper. 2003. “Patient-Physician Relationships and Racial Disparities in the Quality of Health Care.” American Journal of Public Health 93:1713-1719.
68. Saxon, Andrew J. and Dennis McCarty. 2005. “Challenges in the Adoption of New Pharmacotherapies for Addiction to Alcohol and Other Drugs.” Pharmacology and Therapeutics 108:119-128.
69. Schmidt, Laura, Thomas Greenfield, and Nina Mulia. 2006. “Unequal Treatment: Racial and Ethnic Disparities in Alcoholism Treatment Services.” Alcohol Research and Health 29:49-54.
70. Schmidt, Laura A., Yu Ye, Thomas K. Greenfield, and Jason Bond. 2007. “Ethnic Disparities in Clinical Severity and Services for Alcohol Problems: Results from the National Alcohol Survey.” Alcoholism: Clinical and Experimental Research 31:48-56.
71. Schneider, Eric C., Alan M. Zaslavsky, and Arnold M. Epstein. 2002. “Racial Disparities in the Quality of Care for Enrollees in Medicare Managed Care.” JAMA 287:1288-1294.
72. Sclar, David A., Linda M. Robison, Tracy L. Skaer, W. Michael Dickson, Christopher M. Kozma, and C. Eugene Reeder. 1998. “Antidepressant Prescribing Patterns: A Comparison of Blacks and Whites in a Medicaid Population.” Clinical Drug Investigation 16:135-140.
73. Skinner, Jonathan, Amitahh Chandra, Douglas Staiger, Julie Lee, and Mark McClellan. 2005. “Mortality after Acute Myocardial Infarction in Hospitals That Disproportionately Treat Black Patients.” Circulation 112:2634-2641.
74. Smith, David Barton, Zhanlian Feng, Mary L. Fennell, Jacqueline S. Zinn, and Vincent Mor. 2007. “Separate and Unequal: Racial Segregation and Disparities in Quality across U.S. Nursing Homes.” Health Affairs 26:1448-1458.
75. Substance Abuse and Mental Health Services Administration (SAMHSA). 2007. National Survey of Substance Abuse Treatment Services (N-SSATS): 2006. Data on Substance Abuse Treatment Facilities (DASIS Series: S-39, DHHS Publication No. [SMA] 07-4296). Rockville, MD: SAMHSA Office of Applied Studies.
76. Thomas, Cindy Parks, Stanley S. Wallack, Sue Lee, Dennis McCarty, and Robert Swift. 2003. “Research to Practice: Adoption of Naltrexone in Alcoholism Treatment.” Journal of Substance Abuse Treatment 24:1-11.
77. Trivedi, Amal N., Alan M. Zaslavsky, Eric C. Schneider, and John Z. Ayanian. 2005. “Trends in Quality of Care and Racial Disparities in Medicare Managed Care.” New England Journal of Medicine 353:692-700.
78. Turner, Erik H., Annette M. Matthews, Eftihia Linardatos, Robert A. Tell, and Robert Rosenthal. 2008. “Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy.” New England Journal of Medicine 358:252-260.
79. Van Ryn, Michelle and Jane Burke. 2000. “The Effect of Patient Race and Socio-Economic Status on Physicians’ Perceptions of Patients.” Social Science and Medicine 50:813-828.
80. Van Ryn, Michelle and Steven S. Fu. 2003. “Paved with Good Intentions: Do Public Healrh and Human Service Providers Contribute to Racial/Ethnic Disparities in Health?” American Journal of Public Health 93:248-255.
81. Wells, Kenneth, Ruth Klap, Alan Koike, and Cathy Sherbourne. 2001. “Ethnic Disparities in Unmet Need for Alcoholism, Drug Abuse, and Mental Health Care.” American Journal of Psychiatry 158:2027-2032.
82. Williams, David R. and Chiquita Collins. 1995. “U.S. Socioeconomic and Racial Differences in Health: Patterns and Explanations.” Annual Review of Sociology 21:349-386.
83. Williams, David R. and Chiquita Collins. 2001. “Racial Residential Segregation: A Fundamental Cause of Racial Disparities in Health.” Public Health Reports 116:404-416.
84. Williams, David R. and Pamela Braboy Jackson. 2005. “Social Sources of Disparities in Flealth.” Health Affairs 24:325-334.